PLRX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Pliant Therapeutics Inc (PLRX) is not a strong buy for a beginner investor with a long-term strategy at this time. The technical indicators are bearish, the financial performance is weak, and there are no significant positive catalysts or trading signals to suggest immediate upside potential. Given the lack of strong growth trends and the absence of influential insider or congress trading activity, it would be prudent to hold off on investing in this stock for now.
The technical indicators for PLRX are bearish. The MACD histogram is negative and contracting, the RSI is neutral at 33.612, and the moving averages (SMA_200 > SMA_20 > SMA_5) indicate a downward trend. The stock is trading below the pivot level of 1.166, with key support at 1.107 and resistance at 1.225.
Hedge funds have increased their buying activity by 138.46% over the last quarter, which could indicate institutional interest.
There are no recent news updates, no congress trading data, and no significant insider activity. Additionally, the stock lacks any Intellectia Proprietary Trading Signals.
In Q3 2025, PLRX reported zero revenue growth (0.00% YoY), a net income drop to -$26.3M (-54.47% YoY), and an EPS decline to -0.43 (-54.74% YoY). Gross margin remained at zero, showing no improvement.
No recent analyst rating or price target changes are provided. Wall Street sentiment is unclear, and there is no strong consensus on the stock.
